pI: 6.6424 |
Length (AA): 2569 |
MW (Da): 289614 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
771 | 1675 | 1u6g (C) | 207 | 1186 | 13.00 | 0.18 | 0.96 | 0.304877 | 1.05 |
1332 | 1573 | 5jo8 (A) | 22 | 252 | 11.00 | 0 | 0.06 | 0.1528 | -0.01 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128900)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G36080 | phosphotransferases/inositol or phosphatidylinositol kinases |
Arabidopsis thaliana | AT2G17930 | phosphatidylinositol 3- and 4-kinase family protein with FAT domain |
Babesia bovis | BBOV_III007660 | hypothetical protein |
Brugia malayi | Bm1_43835 | FAT domain containing protein |
Candida albicans | CaO19.3451 | similar to C terminus of S. cerevisiae TRA1 (YHR099W) histone acetyltransferase complex component |
Candida albicans | CaO19.139 | similar to N terminus of S. cerevisiae TRA1 (YHR099W) histone acetyltransferase complex component |
Candida albicans | CaO19.10955 | similar to C terminus of S. cerevisiae TRA1 (YHR099W) histone acetyltransferase complex component |
Candida albicans | CaO19.7783 | similar to N terminus of S. cerevisiae TRA1 (YHR099W) histone acetyltransferase complex component |
Caenorhabditis elegans | CELE_C47D12.1 | Protein TRR-1, isoform C |
Cryptosporidium hominis | Chro.60211 | phosphatidylinositol kinase-like protein |
Cryptosporidium parvum | cgd6_1740 | Tra1p-like; C-terminal FAT domain plus phoshoinositide 3-kinase domain; very large protein |
Dictyostelium discoideum | DDB_G0281947 | PIKK family protein kinase |
Drosophila melanogaster | Dmel_CG33554 | CG33554 gene product from transcript CG33554-RE |
Echinococcus granulosus | EgrG_001178700 | PIK kinase FAT and Armadillo domain containing protein |
Echinococcus multilocularis | EmuJ_001178700 | PIK kinase, FAT and Armadillo domain containing protein |
Homo sapiens | ENSG00000196367 | transformation/transcription domain-associated protein |
Loa Loa (eye worm) | LOAG_08898 | hypothetical protein |
Loa Loa (eye worm) | LOAG_04605 | hypothetical protein |
Loa Loa (eye worm) | LOAG_03414 | hypothetical protein |
Loa Loa (eye worm) | LOAG_11724 | hypothetical protein |
Mus musculus | ENSMUSG00000045482 | transformation/transcription domain-associated protein |
Neospora caninum | NCLIV_037840 | hypothetical protein |
Oryza sativa | 4344092 | Os07g0645100 |
Oryza sativa | 9270052 | Os07g0645200 |
Saccharomyces cerevisiae | YHR099W | Tra1p |
Schistosoma japonicum | Sjp_0039160 | ko:K08874 transformation/transcription domain-associated protein, putative |
Schistosoma mansoni | Smp_135260 | choline/ethanolaminephosphotransferase 1 |
Schmidtea mediterranea | mk4.006712.07 | |
Schmidtea mediterranea | mk4.036138.00 | Transcription-associated protein 1 |
Schmidtea mediterranea | mk4.006712.00 | |
Schmidtea mediterranea | mk4.016941.00 | Transcription-associated protein 1 |
Schmidtea mediterranea | mk4.006712.01 | Transcription-associated protein 1 |
Schmidtea mediterranea | mk4.006712.06 | |
Schmidtea mediterranea | mk4.006712.04 | |
Schmidtea mediterranea | mk4.006712.05 | Transcription-associated protein 1 |
Toxoplasma gondii | TGME49_268370 | non-specific serine/threonine protein kinase |
Theileria parva | TP04_0665 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_C47D12.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C47D12.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C47D12.1 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C47D12.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C47D12.1 | Caenorhabditis elegans | sterile | wormbase |
YHR099W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_268370 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.